Get startedLog in
    Picture of CARsgen Therapeutics Holdings logo

    2171 — CARsgen Therapeutics Holdings News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapMomentum Trap
    All News

    Brief: CARsgen Presents Data From China Study Of Cancer Therapy At 2022 ASH Annual Meeting

    Picture of CARsgen Therapeutics Holdings logoCARsgen Therapeutics Holdings
    12/12/2022 14:34
    Dec 12 (Reuters) - CARsgen Therapeutics Holdings Ltd
 2171.HK :
    * CARSGEN PRESENTS DATA FROM CHINA PIVOTAL PHASE II TRIAL OF
BCMA
CAR T ZEVOR-CEL (CT053) AT 2022 ASH ANNUAL MEETING

Source text for Eikon:  ID:nPn2vhJrZa 
Further company coverage:  2171.HK 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on CARsgen Therapeutics Holdings

    See all news